United States · FDA National Drug Code directory
Lisdexamfetamine dimesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-604_d6435613-e052-4b4f-8bf7-4acb7458d8df
- Product NDC
- 43547-604
- Form
- CAPSULE
- Composition / generic term
- Lisdexamfetamine dimesylate capsules
- Labeler
- Solco Healthcare US,LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230826
- Source listing expiry
- 20271231
Source-listed ingredients
- LISDEXAMFETAMINE DIMESYLATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (43547-604-10) · 43547-604-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →